Multiple sclerosis diagnostic criteria: three years later.
about
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaRelevance of quality of life assessment for multiple sclerosis patients with memory impairmentVariants of ST8SIA1 are associated with risk of developing multiple sclerosis.Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.A myelin-specific contrast agent for magnetic resonance imaging of myelinationCognitive function and quality of life in multiple sclerosis patients: a cross-sectional studyMRI pattern recognition in multiple sclerosis normal-appearing brain areas.Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional studyMicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).A patient care program for adjusting the autoinjector needle depth according to subcutaneous tissue thickness in patients with multiple sclerosis receiving subcutaneous injections of glatiramer acetate.Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension studyGlial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosisNeurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromesProlonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort studyWhat is the relevance of quality of life assessment for patients with attention impairment?Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodologySerum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis.From the Gothenburg cohort to the Swedish multiple sclerosis registry.Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland.Cognitive linguistic deficits in relapsing–remitting multiple sclerosis
P2860
Q24605493-2A60FF30-6E60-46FC-A543-64E207A87581Q31108979-D4ADDC96-F7BC-43D5-8B08-53A6581C5FF0Q33350182-ABA6A291-1A05-4EFF-9F04-CAAD0BE44100Q33687644-43FE4239-37D0-4825-A6EB-24E45577A599Q33803236-2A2C8A89-8D5B-43F7-9DB8-CDAF241BE966Q33810669-0BAE95EC-CECE-4796-8FBE-A4554932CC54Q33939194-CF90350F-64C4-488C-AB44-E4BBDB864BB8Q34146255-7279909B-8A76-467E-85AE-DC92D7E865E0Q34878368-C088F01E-242B-4153-9BAD-6E7A34FEA3B0Q35100874-5A2B183C-F687-4EB5-BCF0-47968FF7758DQ35159288-BE445208-08E4-4E73-A672-4E29E73EA4C0Q35330799-820E8271-4DB0-45D5-8C4B-22C648A4ECB9Q35864382-C0637940-52CF-4300-968C-2CFE6DD48A0AQ36226562-9BB8A7C6-989D-4A29-BD3D-54A62EA00D15Q36568921-5EB048D5-BB85-4C8A-8910-DEEA9E5DB219Q36767262-9C0C8E48-65D5-498C-A42B-29EBA0CBACD9Q36808587-F1032DF8-62D2-4233-9DEC-760C7BB5CB9DQ37104937-F83B5936-382F-49AA-B592-85B0B9ABCF82Q37370757-E43A5757-EF47-4308-8997-F53384559F47Q38070772-BEBDC646-5F94-4EEF-9AB3-8ECF5DE51D1CQ38154241-C7B7A220-C6E2-4120-B14B-EFE14D2BC41DQ40110864-97ADD6DF-E84A-4941-9BE4-94A5A4C59AD2Q41139837-232FFD54-DB8D-4570-9A4E-7B4782FD491AQ45037915-1FB438C3-7B94-48E8-A314-6287137C7726Q45344837-C561986C-705E-4F3F-AFA4-08A7466910ADQ46480272-99EF2FB2-6263-49CD-AE00-C32BF73FF12CQ55396508-ED8F0A28-4B23-4F75-AC00-A7776881C517Q58145879-A580213F-5580-4237-9360-CEAA6FE81758
P2860
Multiple sclerosis diagnostic criteria: three years later.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Multiple sclerosis diagnostic criteria: three years later.
@ast
Multiple sclerosis diagnostic criteria: three years later.
@en
type
label
Multiple sclerosis diagnostic criteria: three years later.
@ast
Multiple sclerosis diagnostic criteria: three years later.
@en
prefLabel
Multiple sclerosis diagnostic criteria: three years later.
@ast
Multiple sclerosis diagnostic criteria: three years later.
@en
P2093
P2860
P1476
Multiple sclerosis diagnostic criteria: three years later.
@en
P2093
Chris H Polman
Jerry S Wolinsky
Stephen C Reingold
P2860
P356
10.1191/1352458505MS1135OA
P577
2005-02-01T00:00:00Z